Corporate
Agios Wins Historic FDA Approval: AQVESME Becomes First Oral Therapy for Broad Thalassemia Population
Dec 24, 2025
You're signed outSign in or to get full access.
Leadership at AGIOS PHARMACEUTICALS
Browse executives, board members, and key leadership.
Executives at AGIOS PHARMACEUTICALS
Brian Goff
Chief Executive Officer
CEO
Executive
Board
Cecilia Jones
Chief Financial Officer
Executive
James Burns
Chief Legal Officer
Executive
Krishnan Viswanadhan
Chief Corporate Development & Strategy Officer
Executive
Sarah Gheuens
Chief Medical Officer, Head of Research & Development
Executive
Tsveta Milanova
Chief Commercial Officer
Executive